Compare NVST & IRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NVST | IRTC |
|---|---|---|
| Founded | 2018 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8B | 4.8B |
| IPO Year | 2019 | 2016 |
| Metric | NVST | IRTC |
|---|---|---|
| Price | $29.42 | $128.46 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 13 |
| Target Price | $24.85 | ★ $209.69 |
| AVG Volume (30 Days) | ★ 3.4M | 615.7K |
| Earning Date | 05-07-2026 | 05-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 104.31 | 61.71 |
| EPS | ★ 0.28 | N/A |
| Revenue | ★ $2,566,500,000.00 | $747,138,000.00 |
| Revenue This Year | $6.67 | $18.26 |
| Revenue Next Year | $3.52 | $15.44 |
| P/E Ratio | $104.93 | ★ N/A |
| Revenue Growth | N/A | ★ 26.24 |
| 52 Week Low | $14.22 | $92.52 |
| 52 Week High | $30.42 | $210.01 |
| Indicator | NVST | IRTC |
|---|---|---|
| Relative Strength Index (RSI) | 66.47 | 32.65 |
| Support Level | $19.29 | N/A |
| Resistance Level | $30.42 | $167.19 |
| Average True Range (ATR) | 0.98 | 8.07 |
| MACD | -0.08 | -1.30 |
| Stochastic Oscillator | 59.60 | 11.70 |
Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments; Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment, which derives key revenue, develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. Geographically, the company generates a majority of its revenue from North America, followed by Western Europe and other developed and emerging markets.
iRhythm Holdings Inc formerly, iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.